Antibody-Mediated Rejection (AMR) in Kidney Transplantation: The Role of Anti-Peroxisomal trans-2-enoyl-CoA Reductase (PECR) Auto-Antibody.

被引：0
|
作者：
Freitas, M. [1 ]
Rebellato, L. [2 ]
Pham, T. [1 ]
Terasaki, P. [1 ]
机构：
[1] Terasaki Fdn Lab, Los Angeles, CA USA
[2] E Carolina Univ, Brody Sch Med, Dept Pathol, Greenville, NC 27858 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2013年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：333 / 333
页数：1
相关论文
共 50 条
  • [41] Single-cell and bulk RNA sequencing highlights the role of M1-like infiltrating macrophages in antibody-mediated rejection after kidney transplantation
    Pang, Qidan
    Chen, Liang
    An, Changyong
    Zhou, Juan
    Xiao, Hanyu
    HELIYON, 2024, 10 (06)
  • [42] Postoperative Rebound of Anti-Blood Type Antibodies and Antibody-Mediated Rejection After ABO-Incompatible Living Related Kidney Transplantation - Is Prophylactic Treatment Necessary?
    Ishida, H.
    Kondo, T.
    Shimizu, T.
    Nozaki, T.
    Tanabe, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 601 - 601
  • [43] Rabbit anti-human thymocyte immunoglobulin for the rescue treatment of chronic antibody-mediated rejection after pediatric kidney transplantation (vol 32, pg 2133, 2017)
    Cihan, Yasemen
    Kanzelmeyer, Nele
    Drube, Jens
    Kreuzer, Martin
    Lerch, Christian
    Hennies, Imke
    Froede, Kerstin
    Verboom, Murielle
    Ahlenstiel-Grunow, Thurid
    Pape, Lars
    PEDIATRIC NEPHROLOGY, 2018, 33 (04) : 727 - 727
  • [44] Postoperative rebound of anti-blood type antibodies and antibody-mediated rejection after ABO-incompatible living related kidney transplantation: Is prophylactic treatment necessary?
    Ishida, Hideki
    Shimizu, Tomokazu
    Omoto, Kazuya
    Okumi, Masayoshi
    Omoto, Kazunari
    TRANSPLANTATION, 2016, 100 (07) : S715 - S715
  • [45] Pre-transplant crossmatch-negative donor-specific anti-HLA antibody predicts acute antibody-mediated rejection but not long-term outcomes in kidney transplantation: an analysis of the Korean Organ Transplantation Registry
    Lee, Haeun
    Lee, Hanbi
    Sun, In O.
    Park, Jung Hwan
    Park, Jong-Won
    Ban, Tae Hyun
    Yang, Jaeseok
    Kim, Myoung Soo
    Yang, Chul Woo
    Chung, Byung Ha
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [46] LATE ANTIBODY-MEDIATED REJECTION (ABMR) AFTER KIDNEY TRANSPLANTATION - ROLE OF THE EGFR SLOPE WITHIN THE FIRST YEAR AFTER BIOPSY AS A SURROGATE ENDPOINT PREDICTING GRAFT FAILURE
    Eskandary, Farsad
    Dumler, Anita
    Regele, Heinz
    Kainz, Alexander
    Doberer, Konstantin
    Strassl, Robert
    Bond, Gregor
    Wahrmann, Markus
    Boehmig, Georg
    HUMAN IMMUNOLOGY, 2019, 80 : 214 - 214
  • [47] LATE ANTIBODY-MEDIATED REJECTION (ABMR) AFTER KIDNEY TRANSPLANTATION - ROLE OF THE EGFR SLOPE WITHIN THE FIRST YEAR AFTER BIOPSY AS A SURROGATE ENDPOINT PREDICTING GRAFT FAILURE
    Dumler, A.
    Eskandary, F.
    Regele, H.
    Doberer, K.
    Kainz, A.
    Strassl, R.
    Bond, G.
    Wahrmann, M.
    Boehmig, G. A.
    TRANSPLANT INTERNATIONAL, 2018, 31 : 19 - 19
  • [48] POSTOPERATIVE REBOUND OF ANTI-BLOOD TYPE ANTIBODIES AND ANTIBODY-MEDIATED REJECTION AFTER ABO-INCOMPATIBLE LIVING RELATED KIDNEY TRANSPLANTATION. -IS PROPHYLACTIC TREATMENT NECESSARY?
    Hideki, Ishida
    Shimizu, Tomokazu
    Nozaki, Taiji
    Omoto, Kazuya
    Okumi, Masayoshi
    Tanabe, Kazunari
    TRANSPLANT INTERNATIONAL, 2015, 28 : 2 - 3
  • [49] Sequential administration of anti-complement component C5 eculizumab and type-2 anti-CD20 obinutuzumab for the treatment of early antibody-mediated rejection after kidney transplantation: A proof of concept
    Favi, Evaldo
    Cresseri, Donata
    Perego, Marta
    Ikehata, Masami
    Iesari, Samuele
    Campise, Maria Rosaria
    Morello, William
    Testa, Sara
    Sioli, Viviana
    Mattinzoli, Deborah
    Longhi, Elena
    Del Gobbo, Alessandro
    Castellano, Giuseppe
    Ferraresso, Mariano
    CLINICAL IMMUNOLOGY, 2024, 264
  • [50] Effect of low-dose rituximab induction therapy for donor-specific Anti-HLA-Antibody (DSA) positive kidney transplant recipients: Marked reduction in DSA and antibody-mediated rejection after renal transplantation.
    Tanabe, Kazunari
    Ishida, Hideki
    Omoto, Kazuya
    Shimizu, Tomokazu
    Shirakawa, Hiroki
    Nishida, Hayato
    Tokumoto, Tadahiko
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 235 - 235
12345